(Total Views: 171)
Posted On: 04/01/2025 8:59:42 AM
Post# of 2473

2024 Annual Report Filed March 30, 2025 - Key Points
Total Assets Values - December 31, 2024 vs December 31, 2023
$19,968,195 vs $17,075,362 - up $2,892,833 - up 16.9%
Total Liabilities - December 31, 2024 vs December 31, 2023
$1,311,010 vs $1,591,532 - down $280,522 - down 17.6%
Total Expenses - December 31, 2024 vs December 31, 2023
$617,207 vs $1,914,000 - down $1,296,793 - down 67.75%
Net Operating Gain (Loss) - December 31, 2024 vs December 31, 2023
Profit $286,223 vs Loss $979,173 - up $1,265,396
Total Assets Values - December 31, 2024 vs December 31, 2023
$19,968,195 vs $17,075,362 - up $2,892,833 - up 16.9%
Total Liabilities - December 31, 2024 vs December 31, 2023
$1,311,010 vs $1,591,532 - down $280,522 - down 17.6%
Total Expenses - December 31, 2024 vs December 31, 2023
$617,207 vs $1,914,000 - down $1,296,793 - down 67.75%
Net Operating Gain (Loss) - December 31, 2024 vs December 31, 2023
Profit $286,223 vs Loss $979,173 - up $1,265,396


"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.